EP2079839A4 - Assessment of risk for colorectal cancer - Google Patents

Assessment of risk for colorectal cancer

Info

Publication number
EP2079839A4
EP2079839A4 EP08714743A EP08714743A EP2079839A4 EP 2079839 A4 EP2079839 A4 EP 2079839A4 EP 08714743 A EP08714743 A EP 08714743A EP 08714743 A EP08714743 A EP 08714743A EP 2079839 A4 EP2079839 A4 EP 2079839A4
Authority
EP
European Patent Office
Prior art keywords
assessment
risk
colorectal cancer
colorectal
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08714743A
Other languages
German (de)
French (fr)
Other versions
EP2079839A1 (en
Inventor
Michelle Cotterchio
Steven Gallinger
Celia Greenwood
Thomas J Hudson
Brent W Zanke
Michael Phillips
Saravanan Sundararajan
Alexandre Montpetit
Phillippe Laflamme
Vincent Ferretti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Cancer Care Ontario
Original Assignee
McGill University
Cancer Care Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007901147A external-priority patent/AU2007901147A0/en
Application filed by McGill University, Cancer Care Ontario filed Critical McGill University
Priority to EP10007611A priority Critical patent/EP2243834A1/en
Publication of EP2079839A1 publication Critical patent/EP2079839A1/en
Publication of EP2079839A4 publication Critical patent/EP2079839A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP08714743A 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer Withdrawn EP2079839A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10007611A EP2243834A1 (en) 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007901147A AU2007901147A0 (en) 2007-03-05 Assessment of risk for colorectal cancer
PCT/CA2008/000424 WO2008106785A1 (en) 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer

Publications (2)

Publication Number Publication Date
EP2079839A1 EP2079839A1 (en) 2009-07-22
EP2079839A4 true EP2079839A4 (en) 2009-11-18

Family

ID=39737739

Family Applications (2)

Application Number Title Priority Date Filing Date
EP10007611A Withdrawn EP2243834A1 (en) 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer
EP08714743A Withdrawn EP2079839A4 (en) 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10007611A Withdrawn EP2243834A1 (en) 2007-03-05 2008-03-05 Assessment of risk for colorectal cancer

Country Status (5)

Country Link
US (1) US20110189663A1 (en)
EP (2) EP2243834A1 (en)
AU (1) AU2008222563A1 (en)
CA (1) CA2679954A1 (en)
WO (1) WO2008106785A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009047532A2 (en) * 2007-10-12 2009-04-16 Cancer Research Technology Limited Cancer susceptibility loci
GB0904382D0 (en) * 2009-03-13 2009-04-29 Univ Dundee Treatment of cell proliferation and differentiation disorders
EP2267153A1 (en) * 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification of netrin-1 receptor unc5c gene mutation in solid cancers
US20120102054A1 (en) * 2010-10-25 2012-04-26 Life Technologies Corporation Systems and Methods for Annotating Biomolecule Data
US11453646B2 (en) 2011-07-27 2022-09-27 Cornell University Methods for RNA detection and quantification
WO2013055822A2 (en) 2011-10-11 2013-04-18 Life Technologies Corporation Systems and methods for analysis and interpretation of nucleic acid sequence data
US20130282390A1 (en) * 2012-04-20 2013-10-24 International Business Machines Corporation Combining knowledge and data driven insights for identifying risk factors in healthcare
US9664676B2 (en) * 2013-09-06 2017-05-30 Cornell University RNA sequences that induce fluorescence of small molecule fluorophores
WO2017214632A2 (en) * 2016-06-10 2017-12-14 University Of Wyoming Recombinant insect vectors and methods of use
EP3541939A4 (en) 2016-11-17 2020-06-24 Ramot at Tel-Aviv University Ltd. Modulators of human kai1 metastasis suppressor gene, methods and uses thereof
KR20220031927A (en) * 2019-08-09 2022-03-14 베이징 다베이농 바이오테크놀로지 컴퍼니 리미티드 Nucleic acid sequence for detecting soybean plant DBN8002 and detection method thereof
CN115515680A (en) * 2020-03-06 2022-12-23 索元生物医药有限公司 Compositions and methods for assessing efficacy of neurotransmitter transporter inhibitors
WO2022061112A1 (en) * 2020-09-18 2022-03-24 Board Of Regents, The University Of Texas System Combination treatment for cancer

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4109496A (en) 1977-12-20 1978-08-29 Norris Industries Trapped key mechanism
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
JPS6147500A (en) 1984-08-15 1986-03-07 Res Dev Corp Of Japan Chimera monoclonal antibody and its preparation
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
US5656493A (en) 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1987002671A1 (en) 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
JP2874751B2 (en) 1986-04-09 1999-03-24 ジェンザイム・コーポレーション Transgenic animals secreting the desired protein into milk
US4851331A (en) 1986-05-16 1989-07-25 Allied Corporation Method and kit for polynucleotide assay including primer-dependant DNA polymerase
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ATE135370T1 (en) 1988-12-22 1996-03-15 Kirin Amgen Inc CHEMICALLY MODIFIED GRANULOCYTE COLONY EXCITING FACTOR
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991006666A1 (en) 1989-11-06 1991-05-16 Cell Genesys, Inc. Production of proteins using homologous recombination
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US6013431A (en) 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0814159B1 (en) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
DE4214112A1 (en) 1991-08-02 1993-02-04 Europ Lab Molekularbiolog NEW METHOD FOR SEQUENCING NUCLEIC ACIDS
CA2087413A1 (en) 1992-01-17 1993-07-18 Joseph R. Lakowicz Fluorescent energy transfer immunoassay
GB9208733D0 (en) 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
GB9211979D0 (en) 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues
CA2148252C (en) 1992-10-30 2007-06-12 Roger Brent Interaction trap system for isolating novel proteins
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
JPH08509857A (en) 1993-01-07 1996-10-22 シーケノム・インコーポレーテッド DNA sequencing method by mass spectrometry
US6194144B1 (en) 1993-01-07 2001-02-27 Sequenom, Inc. DNA sequencing by mass spectrometry
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
WO1995014108A1 (en) 1993-11-17 1995-05-26 Amersham International Plc Primer extension mass spectroscopy nucleic acid sequencing method
JP3175110B2 (en) 1994-02-07 2001-06-11 オーキッド・バイオサイエンシーズ・インコーポレイテッド Genetic bit analysis of ligase / polymerase mediated single nucleotide polymorphisms and their use in genetic analysis
AU693198B2 (en) 1994-04-25 1998-06-25 Avitech Diagnostics, Inc. Detection of mutation by resolvase cleavage
US5851770A (en) 1994-04-25 1998-12-22 Variagenics, Inc. Detection of mismatches by resolvase cleavage using a magnetic bead support
US5834189A (en) 1994-07-08 1998-11-10 Visible Genetics Inc. Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types
US5849483A (en) 1994-07-28 1998-12-15 Ig Laboratories, Inc. High throughput screening method for sequences or genetic alterations in nucleic acids
US5589330A (en) 1994-07-28 1996-12-31 Genzyme Corporation High-throughput screening method for sequence or genetic alterations in nucleic acids using elution and sequencing of complementary oligonucleotides
US6239273B1 (en) 1995-02-27 2001-05-29 Affymetrix, Inc. Printing molecular library arrays
DE19515552A1 (en) 1995-04-27 1996-10-31 Europ Lab Molekularbiolog Simultaneous sequencing of nucleic acids
US6077664A (en) 1995-06-07 2000-06-20 Promega Corporation Thermophilic DNA polymerases from Thermotoga neapolitana
US5981186A (en) 1995-06-30 1999-11-09 Visible Genetics, Inc. Method and apparatus for DNA-sequencing using reduced number of sequencing mixtures
JP3193301B2 (en) 1995-09-14 2001-07-30 麒麟麦酒株式会社 Bioactive protein p160
US5869242A (en) 1995-09-18 1999-02-09 Myriad Genetics, Inc. Mass spectrometry to assess DNA sequence polymorphisms
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
US6022688A (en) 1996-05-13 2000-02-08 Sequenom, Inc. Method for dissociating biotin complexes
CA2258511A1 (en) 1996-06-14 1997-12-18 Sarnoff Corporation Method for polynucleotide sequencing
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
US5900481A (en) 1996-11-06 1999-05-04 Sequenom, Inc. Bead linkers for immobilizing nucleic acids to solid supports
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6017702A (en) 1996-12-05 2000-01-25 The Perkin-Elmer Corporation Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate
US5876934A (en) 1996-12-18 1999-03-02 Pharmacia Biotech Inc. DNA sequencing method
US6046005A (en) 1997-01-15 2000-04-04 Incyte Pharmaceuticals, Inc. Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group
ATE264523T1 (en) 1997-07-25 2004-04-15 Affymetrix Inc A Delaware Corp METHOD FOR CREATING A BIO-INFORMATICS DATABASE
JP2001514907A (en) 1997-08-15 2001-09-18 アフィメトリックス・インコーポレーテッド Polymorph detection using cluster analysis
US5998143A (en) 1997-12-05 1999-12-07 The Perkin-Elmer Corporation Cycle sequencing thermal profiles
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
DE69902996T2 (en) 1998-02-04 2003-04-30 Variagenics, Inc. MISCELLANEOUS DETECTION TECHNIQUES
US6183958B1 (en) 1998-05-06 2001-02-06 Variagenics, Inc. Probes for variance detection
US6140054A (en) 1998-09-30 2000-10-31 University Of Utah Research Foundation Multiplex genotyping using fluorescent hybridization probes
US6142681A (en) 1999-02-22 2000-11-07 Vialogy Corporation Method and apparatus for interpreting hybridized bioelectronic DNA microarray patterns using self-scaling convergent reverberant dynamics
US6136541A (en) 1999-02-22 2000-10-24 Vialogy Corporation Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions
JP2003508078A (en) 1999-09-03 2003-03-04 イエール ユニバーシティー Methods for identifying gene function using small molecule probes
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6448010B1 (en) 1999-10-06 2002-09-10 Amersham Pharmacia Biotech, Inc. Method for detecting mutations using arrayed primer extension
US6221600B1 (en) 1999-10-08 2001-04-24 Board Of Regents, The University Of Texas System Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis
US6297016B1 (en) 1999-10-08 2001-10-02 Applera Corporation Template-dependent ligation with PNA-DNA chimeric probes
CA2386791A1 (en) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Method and apparatus for performing large numbers of reactions using array assembly
US6709816B1 (en) 1999-10-18 2004-03-23 Affymetrix, Inc. Identification of alleles
AU2001249622B2 (en) 2000-03-30 2007-06-07 Massachusetts Institute Of Technology RNA sequence-specific mediators of RNA interference
JP2005508306A (en) 2001-07-23 2005-03-31 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Methods and compositions relating to RNAi inhibition of gene expression in mammals
US6872533B2 (en) * 2001-07-27 2005-03-29 The Regents Of The University Of California STK15 (STK6) gene polymorphism and methods of determining cancer risk
IL163645A0 (en) * 2002-02-21 2005-12-18 Idgene Pharmaceuticals Ltd Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer
EP1716255B1 (en) * 2004-02-20 2015-11-11 Samsung Electronics Co., Ltd. A polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
KR101206029B1 (en) * 2005-04-01 2012-11-28 삼성전자주식회사 Multiple SNP for diagnosing colorectal cancer, microarray and kit comprising the same, and method for diagnosing colorectal cancer using the same
KR101138867B1 (en) * 2005-06-14 2012-05-14 삼성전자주식회사 A polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the same
CA2654165A1 (en) * 2006-06-05 2007-12-13 Cancer Care Ontario Assessment of risk for colorectal cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE DBSNP NCBI; 3 November 2000 (2000-11-03), XP002549042, retrieved from DBSNP - NCBI accession no. http://www.ncbi.nlm.nih.gov/SNP/ Database accession no. rs1763322 *
DATABASE Geneseq [online] 22 February 2002 (2002-02-22), "Oligonucleotide SEQ ID NO 212956 for detecting SNP TSC0051887.", XP002549043, retrieved from EBI accession no. GSN:ABH12979 Database accession no. ABH12979 *
See also references of WO2008106785A1 *

Also Published As

Publication number Publication date
EP2079839A1 (en) 2009-07-22
EP2243834A1 (en) 2010-10-27
CA2679954A1 (en) 2008-09-12
AU2008222563A1 (en) 2008-09-12
US20110189663A1 (en) 2011-08-04
WO2008106785A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
EP2079839A4 (en) Assessment of risk for colorectal cancer
EP2310526A4 (en) Compositions for the detection and treatment of colorectal cancer
IL212905A0 (en) Individualized cancer dignosis
PT2303021T (en) Compounds for the treatment of cancer
HK1143157A1 (en) 4-pyridinone compounds and their use for cancer 4-
EP2310006A4 (en) Treating cancer
IL210504A0 (en) Genetic variants for breast cancer risk assessment
EP2207037A4 (en) Method for detection of cancer
IL202718A0 (en) Preventive/remedy for cancer
IL213398A0 (en) Compounds for treating cancer
GB0820309D0 (en) Detection of cancer
EP2035439A4 (en) Assessment of risk for colorectal cancer
EP2144888A4 (en) Methods for treating cancer
GB0804496D0 (en) Treating cancer
IL209078A0 (en) Methods for assessing colorectal cancer and compositions for use therein
PL2444811T3 (en) Methods for the diagnosis or prognosis of colorectal cancer
EP2117557A4 (en) Compositions and methods for treatment of colorectal cancer
PL388252A1 (en) Combination therapy of colorectal cancer
GB0707556D0 (en) Treatment for cancer
EP2214485A4 (en) Methods for treatment of cancer
EP2363499A4 (en) Colorectal cancer diagnostic method
GB0822345D0 (en) Methods and compositions for cancer prognosis
GB0809046D0 (en) Cancer treatment
AU2007901147A0 (en) Assessment of risk for colorectal cancer
AU2007906337A0 (en) Assessment of risk for colorectal cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091019

17Q First examination report despatched

Effective date: 20100119

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100730

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PHILLIPS, MICHAEL

Inventor name: HUDSON, THOMAS, J.

Inventor name: GREENWOOD, CELIA

Inventor name: LAFLAMME, PHILLIPPE

Inventor name: FERRETTI, VINCENT

Inventor name: GALLINGER, STEVEN

Inventor name: MONTPETIT, ALEXANDRE

Inventor name: SUNDARARAJAN, SARAVANAN

Inventor name: ZANKE, BRENT, W.

Inventor name: COTTERCHIO, MICHELLE